Use in clinical trials
Existing outcome measures used for clinical trials in Parkinson’s are based on subjective patient reported inputs, such as, cumbersome point-in-time rating scales (UPDRS, AIMS) and/or patient diaries which are often inaccurate due to reliance on patient recollection and poor compliance.
The PKG® system is a clinically validated system for objective, ambulatory and continuous assessment of movement disorder symptoms in Parkinson’s disease and can be considered as a measure in clinical studies.
|PKG feature||Benefits in clinical studies|
|PKG is an objective assessment system||
|PKG is easy to use for the clinic and requires minimal involvement by the patient||
|Ability to collect objective motor symptom data during activities of daily living in the patient’s home||
|PKG meets validation and regulatory requirements||
|Comprehensive and robust data delivery||